Clinical

Dataset Information

0

Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC


ABSTRACT: This study is try to evaluate the effect of cetuximab monotherapy as maintenance treatment, versus continuation after 8 courses of induction therapy with cetuximab plus standard chemotherapy regimen (FOLFIRI or mFOLFOX6)in metastatic colorectal cancer (mCRC) patients. The maintenance treatments are continued until disease progression or untolerated toxicity. The aim of this study is to demonstrate that cetuximab monotherapy is non-inferior to continuation treatment, in those mCRC patients who responded to induction therapy(SD, PR, or CR), and carry biomarker-panels (KRAS, NRAS, BRAF, and PIK3CA) favor EGFR antibody.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2228220 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2014-04-01 | E-GEOD-56386 | biostudies-arrayexpress
2014-04-01 | GSE56386 | GEO
2016-05-05 | E-MTAB-3548 | biostudies-arrayexpress
| 2178666 | ecrin-mdr-crc
| 2230951 | ecrin-mdr-crc
2024-07-02 | GSE262796 | GEO
2012-01-01 | E-GEOD-32048 | biostudies-arrayexpress
2021-06-14 | GSE141861 | GEO
2024-10-17 | PXD052949 | Pride
2008-06-14 | E-GEOD-5851 | biostudies-arrayexpress